B-Cell Neoplasm
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms (NCT06508931) | Miltenyi Biomedicine GmbH | 2025-08-04 |
| Systemic Inflammatory Markers in B-cell Neoplasm (NCT06847529) | Assiut University | 2025-03-22 |
| Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas (NCT05389423) | National Cancer Institute (NCI) | 2023-06-27 |
| Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19) (NCT04665115) | Academic and Community Cancer Research United | 2020-11-23 |
| Vaccine Responsiveness After CAR-T Cell Therapy (NCT04410900) | Fred Hutchinson Cancer Center | 2020-08-03 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma (NCT02911142) | National Cancer Institute (NCI) | 2017-07-03 |
| 18F-FSPG PET/CT for Cancer Patients on Therapy (NCT02599194) | Andrei Iagaru | 2015-07-01 |
Track B-Cell Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.